Wegovy weight-loss medication gets FDA approval for use as heart disease prevention drug

The injectable semaglutide from Novo Nordisk was shown to reduce risk of cardiovascular death, heart attack and stroke.

Related Keywords

Texas ,United States ,Dallas ,Boston ,Massachusetts ,John Sharretts ,Brooke Boyarsky Pratt ,Carsten Snejbjerg Bloomberg ,Steffen Trumpf ,Darren Mcguire ,Novo Nordisk ,Division Of Diabetes ,Lipid Disorders ,Drug Evaluation ,Getty Images ,Denmark Based Novo Nordisk ,Boyarsky Pratt ,Fox News ,Fox News Digital ,News Digital ,Health ,News ,Health Care ,Lifestyle ,Fitness Wellbeing ,